Celleron picks up discarded cancer drug from Roche
UK biopharma company signs licensing agreement for emactuzumab
Read MoreUK biopharma company signs licensing agreement for emactuzumab
Read MoreDrug has already been approved in the EU and Japan
Read MoreNHS Confederation forecasts a surge in demand
Read MoreTopline results published from CheckMate-649 and CheckMate-577 studies
Read MoreDeal will include access to investigational menopause drug
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
